Martine Van Vugt

Person

Houten, NL

People

Patents Grantslast 30 patents

Information Patent Grant
Antibodies against CD38 for treatment of multiple myeloma
- Patent number 9,187,565
- Issue date Nov 17, 2015
- Genmab A/S
- Michel De Weers
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-OX40L antibodies
- Patent number 9,102,733
- Issue date Aug 11, 2015
- Roćhe Palo Alto LLC
- Joseph Endl
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Combination treatment of CD38-expressing tumors
- Patent number 9,040,050
- Issue date May 26, 2015
- Genmab A/S
- Jan Van De Winkel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of inhibiting the binding of P-selectin to PSGL-1 with anti...
- Patent number RE44389
- Issue date Jul 23, 2013
- Hoffman-La Roche Inc.
- Yvo Graus
- 424 - Drug, bio-affecting and body treating compositions
Information Patent Grant
Nucleic acid molecules encoding anti-P-selectin antibodies
- Patent number RE44359
- Issue date Jul 9, 2013
- Hoffmann-La Roche Inc.
- Yvo Graus
- 536 - Organic compounds
Information Patent Grant
Anti-P-selectin antibodies
- Patent number RE43568
- Issue date Aug 7, 2012
- Hoffmann-La Roche Inc.
- Yvo Graus
- 424 - Drug, bio-affecting and body treating compositions
Information Patent Grant
Anti-OX40L antibodies
- Patent number 7,868,141
- Issue date Jan 11, 2011
- Roćhe Palo Alto LLC
- Joseph Endl
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibodies against CD38 for treatment of multiple myeloma
- Patent number 7,829,673
- Issue date Nov 9, 2010
- Genmab A/S
- Michel De Weers
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of inhibiting the binding of P-selectin to PSGL-1 with anti...
- Patent number 7,824,684
- Issue date Nov 2, 2010
- Hoffmann-La Roche Inc.
- Yvo Graus
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibodies against IL-13 receptor alpha1 and uses thereof
- Patent number 7,807,158
- Issue date Oct 5, 2010
- Roćhe Palo Alto LLC
- Josef Endl
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Nucleic acid molecules encoding anti-P-selectin antibodies
- Patent number 7,754,867
- Issue date Jul 13, 2010
- Hoffmann-La Roche Inc.
- Yvo Graus
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-P-selectin antibodies
- Patent number 7,563,441
- Issue date Jul 21, 2009
- Hoffman-La Roche Inc.
- Yvo Graus
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-OX40L antibodies
- Patent number 7,501,496
- Issue date Mar 10, 2009
- Roćhe Palo Alto LLC
- Joseph Endl
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
ANTIBODIES AGAINST CD38 FOR TREATMENT OF MULTIPLE MYELOMA
- Publication number 20240228662
- Publication date Jul 11, 2024
- GENMAB A/S
- Michel DE WEERS
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMBINATION TREATMENT OF CD38-EXPRESSING TUMORS
- Publication number 20240165226
- Publication date May 23, 2024
- GENMAB A/S
- Jan Van De Winkel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES AGAINST CD38 FOR TREATMENT OF MULTIPLE MYELOMA
- Publication number 20240132620
- Publication date Apr 25, 2024
- GENMAB A/S
- Michel DE WEERS
- G01 - MEASURING TESTING
Information Patent Application
ANTIBODIES AGAINST CD38 FOR TREATMENT OF MULTIPLE MYELOMA
- Publication number 20200283542
- Publication date Sep 10, 2020
- GENMAB A/S
- Michel DE WEERS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION TREATMENT OF CD38-EXPRESSING TUMORS
- Publication number 20200114000
- Publication date Apr 16, 2020
- GENMAB A/S
- Jan Van De Winkel
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODIES AGAINST CD38 FOR TREATMENT OF MULTIPLE MYELOMA
- Publication number 20160130362
- Publication date May 12, 2016
- GENMAB A/S
- Michel DE WEERS
- G01 - MEASURING TESTING
Information Patent Application
COMBINATION TREATMENT OF CD38-EXPRESSING TUMORS
- Publication number 20150231235
- Publication date Aug 20, 2015
- GENMAB A/S
- Jan VAN DE WINKEL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES AGAINST CD38 FOR TREATMENT OF MULTIPLE MYELOMA
- Publication number 20110099647
- Publication date Apr 28, 2011
- GENMAB A/S
- Michel DE WEERS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES AGAINST IL-13 RECEPTOR ALPHA 1 AND USES THEREOF
- Publication number 20110086026
- Publication date Apr 14, 2011
- Josef Endl
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-OX40L ANTIBODIES
- Publication number 20110070239
- Publication date Mar 24, 2011
- Joseph Endl
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS OF INHIBITING THE BINDING OF P-SELECTIN TO PSGL-1
- Publication number 20100209423
- Publication date Aug 19, 2010
- Yvo Graus
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Anti-OX40L antibodies
- Publication number 20100166740
- Publication date Jul 1, 2010
- Roche Palo Alto LLC.
- Joseph Endl
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMBINATION TREATMENT OF CD38-EXPRESSING TUMORS
- Publication number 20100092489
- Publication date Apr 15, 2010
- GENMAB A/S
- Jan Van De Winkel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-P-SELECTIN ANTIBODIES
- Publication number 20090311779
- Publication date Dec 17, 2009
- Yvo Graus
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Antibodies against CD38 for treatment of multiple myeloma
- Publication number 20090076249
- Publication date Mar 19, 2009
- Michel De Weers
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Antibodies against IL-13 receptor alpha1 and uses thereof
- Publication number 20060263356
- Publication date Nov 23, 2006
- Josef Endl
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Anti-P-selectin antibodies
- Publication number 20050226876
- Publication date Oct 13, 2005
- Yvo Graus
- C07 - ORGANIC CHEMISTRY

Martine Van Vugt

Person

Patents Grantslast 30 patents

Antibodies against CD38 for treatment of multiple myeloma

Anti-OX40L antibodies

Combination treatment of CD38-expressing tumors

Methods of inhibiting the binding of P-selectin to PSGL-1 with anti...

Nucleic acid molecules encoding anti-P-selectin antibodies

Anti-P-selectin antibodies

Anti-OX40L antibodies

Antibodies against CD38 for treatment of multiple myeloma

Methods of inhibiting the binding of P-selectin to PSGL-1 with anti...

Antibodies against IL-13 receptor alpha1 and uses thereof

Nucleic acid molecules encoding anti-P-selectin antibodies

Anti-P-selectin antibodies

Anti-OX40L antibodies

Patents Applicationslast 30 patents

ANTIBODIES AGAINST CD38 FOR TREATMENT OF MULTIPLE MYELOMA

COMBINATION TREATMENT OF CD38-EXPRESSING TUMORS

ANTIBODIES AGAINST CD38 FOR TREATMENT OF MULTIPLE MYELOMA

ANTIBODIES AGAINST CD38 FOR TREATMENT OF MULTIPLE MYELOMA

COMBINATION TREATMENT OF CD38-EXPRESSING TUMORS

ANTIBODIES AGAINST CD38 FOR TREATMENT OF MULTIPLE MYELOMA

COMBINATION TREATMENT OF CD38-EXPRESSING TUMORS

ANTIBODIES AGAINST CD38 FOR TREATMENT OF MULTIPLE MYELOMA

ANTIBODIES AGAINST IL-13 RECEPTOR ALPHA 1 AND USES THEREOF

ANTI-OX40L ANTIBODIES

METHODS OF INHIBITING THE BINDING OF P-SELECTIN TO PSGL-1

Anti-OX40L antibodies

COMBINATION TREATMENT OF CD38-EXPRESSING TUMORS

ANTI-P-SELECTIN ANTIBODIES

Antibodies against CD38 for treatment of multiple myeloma

Antibodies against IL-13 receptor alpha1 and uses thereof

Anti-P-selectin antibodies